2-189043211-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000393.5(COL5A2):​c.3411T>C​(p.Gly1137Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.971 in 1,613,866 control chromosomes in the GnomAD database, including 762,338 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.96 ( 70265 hom., cov: 30)
Exomes 𝑓: 0.97 ( 692073 hom. )

Consequence

COL5A2
NM_000393.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.09

Publications

22 publications found
Variant links:
Genes affected
COL5A2 (HGNC:2210): (collagen type V alpha 2 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. [provided by RefSeq, Jul 2008]
COL5A2 Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome, classic type
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Ehlers-Danlos syndrome, classic type, 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 2-189043211-A-G is Benign according to our data. Variant chr2-189043211-A-G is described in ClinVar as Benign. ClinVar VariationId is 1164098.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.09 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL5A2NM_000393.5 linkc.3411T>C p.Gly1137Gly synonymous_variant Exon 48 of 54 ENST00000374866.9 NP_000384.2 P05997
COL5A2XM_011510573.4 linkc.3273T>C p.Gly1091Gly synonymous_variant Exon 51 of 57 XP_011508875.1
COL5A2XM_047443251.1 linkc.3273T>C p.Gly1091Gly synonymous_variant Exon 53 of 59 XP_047299207.1
COL5A2XM_047443252.1 linkc.3273T>C p.Gly1091Gly synonymous_variant Exon 52 of 58 XP_047299208.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL5A2ENST00000374866.9 linkc.3411T>C p.Gly1137Gly synonymous_variant Exon 48 of 54 1 NM_000393.5 ENSP00000364000.3 P05997
COL5A2ENST00000618828.1 linkc.2250T>C p.Gly750Gly synonymous_variant Exon 41 of 47 5 ENSP00000482184.1 A0A087WYX9

Frequencies

GnomAD3 genomes
AF:
0.960
AC:
146094
AN:
152136
Hom.:
70210
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.947
Gnomad AMI
AF:
1.00
Gnomad AMR
AF:
0.919
Gnomad ASJ
AF:
0.975
Gnomad EAS
AF:
0.910
Gnomad SAS
AF:
0.971
Gnomad FIN
AF:
0.948
Gnomad MID
AF:
0.975
Gnomad NFE
AF:
0.981
Gnomad OTH
AF:
0.959
GnomAD2 exomes
AF:
0.950
AC:
238595
AN:
251182
AF XY:
0.956
show subpopulations
Gnomad AFR exome
AF:
0.949
Gnomad AMR exome
AF:
0.842
Gnomad ASJ exome
AF:
0.972
Gnomad EAS exome
AF:
0.912
Gnomad FIN exome
AF:
0.950
Gnomad NFE exome
AF:
0.981
Gnomad OTH exome
AF:
0.957
GnomAD4 exome
AF:
0.973
AC:
1421624
AN:
1461614
Hom.:
692073
Cov.:
47
AF XY:
0.973
AC XY:
707732
AN XY:
727110
show subpopulations
African (AFR)
AF:
0.946
AC:
31679
AN:
33474
American (AMR)
AF:
0.849
AC:
37973
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.972
AC:
25403
AN:
26132
East Asian (EAS)
AF:
0.886
AC:
35144
AN:
39684
South Asian (SAS)
AF:
0.972
AC:
83824
AN:
86222
European-Finnish (FIN)
AF:
0.953
AC:
50926
AN:
53410
Middle Eastern (MID)
AF:
0.966
AC:
5557
AN:
5752
European-Non Finnish (NFE)
AF:
0.983
AC:
1092560
AN:
1111852
Other (OTH)
AF:
0.970
AC:
58558
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
1846
3693
5539
7386
9232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21646
43292
64938
86584
108230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.960
AC:
146207
AN:
152252
Hom.:
70265
Cov.:
30
AF XY:
0.959
AC XY:
71359
AN XY:
74446
show subpopulations
African (AFR)
AF:
0.947
AC:
39345
AN:
41544
American (AMR)
AF:
0.919
AC:
14050
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.975
AC:
3385
AN:
3472
East Asian (EAS)
AF:
0.910
AC:
4705
AN:
5170
South Asian (SAS)
AF:
0.972
AC:
4683
AN:
4820
European-Finnish (FIN)
AF:
0.948
AC:
10063
AN:
10614
Middle Eastern (MID)
AF:
0.976
AC:
287
AN:
294
European-Non Finnish (NFE)
AF:
0.981
AC:
66750
AN:
68024
Other (OTH)
AF:
0.960
AC:
2027
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
289
578
868
1157
1446
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
912
1824
2736
3648
4560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.969
Hom.:
113534
Bravo
AF:
0.954
Asia WGS
AF:
0.958
AC:
3333
AN:
3478
EpiCase
AF:
0.979
EpiControl
AF:
0.977

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 09, 2025
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

BA1 -

Ehlers-Danlos syndrome, classic type, 2 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Ehlers-Danlos syndrome, classic type, 1 Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
2.8
DANN
Benign
0.50
PhyloP100
1.1
Mutation Taster
=77/23
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6434312; hg19: chr2-189907937; COSMIC: COSV66412801; API